OncoSem Appoints Raj Tugnet as Managing Director of UK Operations

27/10/2025 – Oncosem, Ankara, Türkiye 

Oncosem, a leading innovator in vascular access and infection prevention solutions, today announced the appointment of Raj Tugnet as Managing Director of OncoSem UK Limited, effective 1/11/2025. This strategic appointment marks a significant milestone in OncoSem’s expansion into the United Kingdom and Republic of Ireland markets.

In his new role, Mr. Tugnet will be responsible for establishing and leading OncoSem’s UK operations, with a primary focus on activating the company’s recently awarded NHS Supply Chain framework agreement for needlefree connectors and related vascular access products. He will oversee all operational activities, build the UK sales and marketing team, and drive market penetration across the region.

“We are delighted to welcome Raj to the OncoSem leadership team,” said Erol Çelik, Chief Executive Officer of OncoSem. “His extensive experience in the UK healthcare market, combined with his proven track record in NHS framework activation and commercial leadership, makes him the ideal person to lead our expansion in this strategically important market. Raj’s appointment underscores our commitment to delivering innovative vascular access solutions to healthcare providers across the United Kingdom and Ireland.”

Mr. Tugnet brings over 25 years of experience in the pharmaceutical and medical device industries, with deep expertise in NHS procurement, framework agreements, and healthcare commercialization. Throughout his career, he has successfully led market entry strategies, built high-performing sales teams, and secured significant contract wins with NHS trusts and healthcare organizations across the UK.

“I am thrilled to join Oncosem as part of their leadership team. It is an exciting opportunity to support the company at the forefront of Oncology innovation, dedicated to improving patient care and health outcomes. I look forward to working alongside a talented team, driving strategic growth, and supporting Oncosem’s vision as we continue to expand our impact in the UK, Ireland, and beyond. Together, we will advance solutions that truly make a difference for patients and healthcare providers alike” said Raj Tugnet, Managing Director of OncoSem UK Limited.

OncoSem’s recent success in securing a place on the NHS Supply Chain framework agreement for needlefree connectors positions the company to serve healthcare providers across England, with potential expansion to other regions of the UK and the Republic of Ireland. The framework agreement provides NHS trusts with streamlined access to OncoSem’s comprehensive range of vascular access products, including needlefree connectors, extension sets, and closed system transfer devices.

Mr. Tugnet is based in the United Kingdom.

For more information, visit www.oncosem.com or contact info@oncosem.com